Lipella Pharmaceuticals Inc (LIPO)’s Ratio Roundup: Key Metrics for Trailing Twelve Months

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Lipella Pharmaceuticals Inc’s stock clocked out at $0.45, down -1.18% from its previous closing price of $0.46. In other words, the price has decreased by -$1.18 from its previous closing price. On the day, 2.27 million shares were traded. LIPO stock price reached its highest trading level at $0.5133 during the session, while it also had its lowest trading level at $0.4444.

Ratios:

To gain a deeper understanding of LIPO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.33 and its Current Ratio is at 4.33. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.00.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 14 ’24 when Kaufman Jonathan H bought 10,000 shares for $0.76 per share. The transaction valued at 7,590 led to the insider holds 898,849 shares of the business.

Kaufman Jonathan H bought 30,000 shares of LIPO for $23,649 on Mar 18 ’24. The insider now owns 863,849 shares after completing the transaction at $0.79 per share. On Mar 19 ’24, another insider, Kaufman Jonathan H, who serves as The insider of the company, bought 25,000 shares for $0.87 each. As a result, the insider paid 21,802 and bolstered with 888,849 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIPO now has a Market Capitalization of 3665728 and an Enterprise Value of 2527669. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.09 while its Price-to-Book (P/B) ratio in mrq is 2.02. Its current Enterprise Value per Revenue stands at 4.984.

Stock Price History:

Over the past 52 weeks, LIPO has reached a high of $2.71, while it has fallen to a 52-week low of $0.32. The 50-Day Moving Average of the stock is 4.42%, while the 200-Day Moving Average is calculated to be -32.99%.

Shares Statistics:

It appears that LIPO traded 4.13M shares on average per day over the past three months and 3894910 shares per day over the past ten days. A total of 6.05M shares are outstanding, with a floating share count of 5.16M. Insiders hold about 35.49% of the company’s shares, while institutions hold 7.87% stake in the company. Shares short for LIPO as of 1727654400 were 179856 with a Short Ratio of 0.04, compared to 1724976000 on 219546. Therefore, it implies a Short% of Shares Outstanding of 179856 and a Short% of Float of 3.3800002000000005.

Most Popular